417 related articles for article (PubMed ID: 24635868)
1. Neoadjuvant vs adjuvant therapy for resectable pancreatic cancer: the evolving role of radiation.
Hoffe S; Rao N; Shridhar R
Semin Radiat Oncol; 2014 Apr; 24(2):113-25. PubMed ID: 24635868
[TBL] [Abstract][Full Text] [Related]
2. Role of radiation therapy in patients with resectable pancreatic cancer.
Palta M; Willett C; Czito B
Oncology (Williston Park); 2011 Jul; 25(8):715-21, 727. PubMed ID: 21874833
[TBL] [Abstract][Full Text] [Related]
3. [Pancreatic carcinoma. Optimizing therapy by adjuvant and neoadjuvant therapy?].
Maurer CA; Zgraggen K; Büchler MW
Zentralbl Chir; 1999; 124(5):401-7. PubMed ID: 10420525
[TBL] [Abstract][Full Text] [Related]
4. Role of chemoradiotherapy in the adjuvant and neoadjuvant settings for resectable pancreatic cancer.
Sen N; Falk S; Abrams RA
Clin Oncol (R Coll Radiol); 2014 Sep; 26(9):551-9. PubMed ID: 25024090
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant and neoadjuvant therapies in resectable pancreatic cancer: a systematic review of randomized controlled trials.
D'Angelo FA; Antolino L; La Rocca M; Petrucciani N; Magistri P; Aurello P; Ramacciato G
Med Oncol; 2016 Mar; 33(3):28. PubMed ID: 26883935
[TBL] [Abstract][Full Text] [Related]
6. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant therapy offers longer survival than upfront surgery for poorly differentiated and higher stage pancreatic cancer.
Nurmi A; Mustonen H; Parviainen H; Peltola K; Haglund C; Seppänen H
Acta Oncol; 2018 Jun; 57(6):799-806. PubMed ID: 29241394
[TBL] [Abstract][Full Text] [Related]
8. The role of radiation therapy in pancreatic ductal adenocarcinoma in the neoadjuvant and adjuvant settings.
Franke AJ; Rosati LM; Pawlik TM; Kumar R; Herman JM
Semin Oncol; 2015 Feb; 42(1):144-62. PubMed ID: 25726059
[TBL] [Abstract][Full Text] [Related]
9. Surgical treatment of pancreatic cancer: the role of adjuvant and multimodal therapies.
Kleeff J; Michalski CW; Friess H; Büchler MW
Eur J Surg Oncol; 2007 Sep; 33(7):817-23. PubMed ID: 17331695
[TBL] [Abstract][Full Text] [Related]
10. New developments in the management of borderline resectable pancreatic cancers.
Goodman MD; McPartland S; Huber K; Saif MW
JOP; 2013 Jul; 14(4):334-6. PubMed ID: 23846921
[TBL] [Abstract][Full Text] [Related]
11. Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.
Stokes JB; Nolan NJ; Stelow EB; Walters DM; Weiss GR; de Lange EE; Rich TA; Adams RB; Bauer TW
Ann Surg Oncol; 2011 Mar; 18(3):619-27. PubMed ID: 21213060
[TBL] [Abstract][Full Text] [Related]
12. A neoadjuvant strategy for the management of nonmetastatic pancreatic cancer.
Goff SL; Chabot JA
Cancer J; 2012; 18(6):602-8. PubMed ID: 23187848
[TBL] [Abstract][Full Text] [Related]
13. Perioperative Therapy for Surgically Resectable Pancreatic Adenocarcinoma.
Du L; DeFoe M; Ruzinova MB; Olsen JR; Wang-Gillam A
Hematol Oncol Clin North Am; 2015 Aug; 29(4):717-26. PubMed ID: 26226906
[TBL] [Abstract][Full Text] [Related]
14. Updates on the use of neoadjuvant therapy in borderline resectable pancreatic cancer.
Chandhok NS; Saif MW
JOP; 2014 Mar; 15(2):91-4. PubMed ID: 24618425
[TBL] [Abstract][Full Text] [Related]
15. Therapy of locally advanced pancreatic adenocarcinoma: unresectable and borderline patients.
Kircher SM; Krantz SB; Nimeiri HS; Mulcahy MF; Munshi HG; Benson AB
Expert Rev Anticancer Ther; 2011 Oct; 11(10):1555-65. PubMed ID: 21999129
[TBL] [Abstract][Full Text] [Related]
16. [Adjuvant and neoadjuvant treatment for pancreatic adenocarcinoma in 2006].
Deberne M; Huguet F; Le Scodan R; Hammel P; Andre T
Bull Cancer; 2007 Jan; 94(1):72-80. PubMed ID: 17237007
[TBL] [Abstract][Full Text] [Related]
17. Primarily resectable pancreatic adenocarcinoma - to operate or to refer the patient to an oncologist?
Piątek M; Kuśnierz K; Bieńkowski M; Pęksa R; Kowalczyk M; Nawrocki S
Crit Rev Oncol Hematol; 2019 Mar; 135():95-102. PubMed ID: 30819452
[TBL] [Abstract][Full Text] [Related]
18. [Neoadjuvant therapy in pancreatic cancer].
Ji JF; Li ZY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):644-7. PubMed ID: 16274051
[TBL] [Abstract][Full Text] [Related]
19. The role of neoadjuvant therapy in pancreatic cancer: a review.
Russo S; Ammori J; Eads J; Dorth J
Future Oncol; 2016 Mar; 12(5):669-85. PubMed ID: 26880384
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant therapy or upfront surgery for resectable and borderline resectable pancreatic cancer: A meta-analysis of randomised controlled trials.
van Dam JL; Janssen QP; Besselink MG; Homs MYV; van Santvoort HC; van Tienhoven G; de Wilde RF; Wilmink JW; van Eijck CHJ; Groot Koerkamp B;
Eur J Cancer; 2022 Jan; 160():140-149. PubMed ID: 34838371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]